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Background: Activity Monitors give an objective measure of usual walking performance. This study aimed 
to examine the test-retest reliability of the StepWatch Activity Monitor outputs (mean steps/day; peak activity 
index; sustained activity indices of 1, 5, 20, 30, 60 minutes; steps at high, medium, and low stepping rates). 
Methods: Thirty healthy adults age 18 to 49 years wore the StepWatch for 2 3-day periods at least 1 week 
apart. Results: The intraclass correlation coefficients of the StepWatch outputs ranged from 0.44 to 0.91 over 
3 days. The coefficient of variation ranged from 3.0% to 51.3% over the monitoring periods, with higher 
variation shown for shorter monitoring periods. The most reliable 5 outputs had 95% limits of agreement 
between 3-day periods that were less than 40%. These were mean steps/day (±39.1%), highest step rate in 1 
(±17.3%) and 5 (±37.4%) minutes, peak activity index (±25.6%), and percentage of inactive time (±9.52%). 
Conclusions: Mean steps/day, highest step rate in 1 and 5 minutes, peak activity index, and percentage of 
inactive time have good test-retest reliability over a 3-day monitoring period, with lower reliability shown by 
the other StepWatch outputs. Monitoring over 1 or 2 days is less reliable.
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Activity monitors are used to measure physical activ-
ity in an individual’s natural environment. They contain 
a microprocessor and at least 1 accelerometer and can be 
worn continuously for extended periods. Thus, they are 
able to provide objective information about rate, amount, 
and patterns of physical activity, which may give insight 
into a person’s usual performance.1
The StepWatch Activity Monitor (Orthocare Innova-
tions, 6405 218th St SW, Suite 100, Mountlake Terrace, 
WA 98043–2180, US) is an example of an accelerom-
eter based activity monitor that has been used widely in 
different population groups.2 The StepWatch is small 
(75×50×20 mm) and lightweight (38 g) and is worn at 
the ankle. The monitor contains a custom sensor that 
uses a combination of acceleration, position, and timing 
to detect steps. Thus the outputs of the StepWatch are 
based on the amount, rate, and pattern of walking. The 
StepWatch is calibrated based on each individual’s height 
and gait pattern and the sensitivity can be adjusted for 
individuals with altered gait patterns.
There have been 6 recent studies investigating test-
retest reliability of the StepWatch in participants with 
stroke,3–5 diabetic peripheral neuropathy with or without 
amputations,6 spinal cord injury,7 control participants, and 
participants with a range of neurological disorders.2 All 
of the studies measured mean steps/day, 3 of them over 
a short time period of less than an hour,3,6,7 1 each for 2 
days,4 3 days,5 and 7 days.2 Each of the studies compared 
2 separate time periods within 3 weeks although one study 
did not report statistics.6 Reported intraclass correlation 
coefficients (ICCs) for mean steps/day ranged from 0.86 
to 0.99 representing excellent test-retest reliability.
An advantage of the StepWatch is the range of out-
puts available. In addition to mean steps/day, the data 
can also be presented in numerous other forms. The peak 
activity index is the average step rate of the highest 30 
nonconsecutive minutes over the included time in 1 day. 
Sustained activity measures are also available for 1, 5, 
20, 30, and 60 minutes and are calculated by scanning the 
chosen number of consecutive minutes over the included 
time in 1 day and extracting the maximum number of 
steps achieved in this continuous interval. Thus the peak 
activity index and the sustained activity indices reflect 
rate of walking. In addition the number of steps or the 
duration of time at each step rate (high, medium, and 
low) can be calculated.
The reliability of the additional StepWatch outputs 
has been reported twice previously.2,5 High test-retest reli-
ability was reported particularly for mean steps/day, high-
est stepping rate in 1 and 5 minutes, and the peak activity 
index in 40 adults with stroke over a 3-day monitoring 
period (coefficients of variation 10.7%, 6.7%, 10.2%, and 
7.9%, respectively).5 The reliability of the peak activity 
index, and sustained activity indices for 20, 30, and 60 
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minutes were also reported for 10 adults with a variety 
of neurological disorders and 10 healthy controls2 over 
a 7-day period. Of the reported StepWatch outputs, the 
coefficient of variation was lowest for the peak activity 
index in both the control group and participants with 
neurological disorders (8.5%, 30.6%, respectively). Thus 
reliability testing in healthy participants is limited to only 
10 participants and there is no published information 
on the activity indices for 1 and 5 minutes, which have 
been shown to be repeatable in participants with stroke.5 
Further investigation of test-retest reliability in healthy 
participants is warranted, particularly for the additional 
StepWatch outputs.
Thus, the major aim of this study was to assess the 
test-retest reliability of the StepWatch outputs (total step 
count; peak activity index; sustained activity indices of 
1, 5, 20, 30, 60 minutes; steps at high, medium, and low 
stepping rates) during 2 3-day periods at least 1 week 
apart in healthy adults. A secondary aim was to assess 
test-retest reliability over shorter monitoring periods of 1 
day (the first day of each 3-day monitoring period) and 2 
days (the first 2 days of each 3-day monitoring period).
Methods
A convenience sample of 30 healthy adults was recruited 
from advertising at AUT University. Participants were 
eligible for inclusion if they were 18 years of age or over. 
Individuals were excluded if they had a health condition 
that might impact their ability to participate, such as a 
recent injury limiting activity levels (eg, sprained ankle, 
back pain). All participants gave written informed con-
sent, and the study was approved by the AUT University 
Ethics Committee.
All participants attended the Health and Rehabilita-
tion Research Centre (HRRC) for initial testing. A Step-
Watch activity monitor was calibrated and attached to 
the lateral side of the ankle of the right leg with a Velcro 
strap. The monitor has an infrared light that flashes with 
every step, which was matched to a manual count of steps 
during overground walking at 3 walking speeds (fast, 
slow, and self selected) for 5 meters each. The sensitivity 
and cadence settings were adjusted, if necessary, until 
the flashes corresponded exactly with the manual count 
during the 3 walking speeds. Participants were instructed 
to wear the monitor for 3 days and for the same 3 days the 
following week, removing it for sleeping, swimming, and 
showering. Participants were given an instruction sheet 
with details about the care of the StepWatch. Participants 
returned to the HRRC for a subsequent session where the 
data were downloaded.
Statistical Analyses
ICCs were calculated to assess test-retest reliability 
between the means of each 3-day period for each Step-
Watch output. An ICC of above 0.75 was considered to 
indicate excellent test-retest reliability.8 The 95% limits 
of agreement between the means of each 3-day period 
for each StepWatch output were also calculated as a coef-
ficient of repeatability.9 Bland and Altman advocate plot-
ting the difference between the 2 measurements against 
the mean of the 2 measurements for each participant and 
then calculating 95% limits of agreement as the range 
of differences falling within the mean difference ± 1.96 
standard deviations.9,10 The 95% limits of agreement 
represent the repeatability of the measure from week to 
week and can be expressed either as absolute numbers or 
percentage differences between the first and second test-
ing sessions. In this paper, the 95% limits of agreement 
are reported both as absolute numbers and percentage 
differences to allow comparison of repeatability between 
the different outputs. The coefficient of variation was also 
calculated (standard deviation expressed as a percentage 
of the mean) between the means of each 3-day period.11
To assess the reliability of 1- and 2-day monitoring 
periods, the same statistical tests were used to determine 
the level of agreement between the first day and the first 
2 days of each monitoring period.
Bland-Altman calculations were performed using 
GraphPad Prism (Version 4.03; GraphPad Software Inc, 
11452 El Camino Real, #215 San Diego, CA 92130, US), 
ICCs were calculated by SPSS (Version 14.0.0; SPSS Inc. 
Headquarters, 233 S. Wacker Drive, Chicago, IL 60606, 
US) and the coefficient of variation was calculated in 
Excel 2003 (Microsoft Corporation, One Microsoft Way, 
Redmond, WA 98052–7329, US).
Results
Thirty participants enrolled in the study. Half of the par-
ticipants wore the StepWatch for 2 periods of 3 days as 
instructed, however the other 15 (50%) only completed 
2 monitoring periods of 2 days. Of the 30 participants 
with a mean (SD) age of 27.7 (8.9) years, 15 were men. 
Twelve (40%) participants were students, 9 (30%) indi-
viduals were employed, and 9 (30%) were not employed. 
Chi-square tests for independence indicated no signifi-
cant difference of sex (P = .47) or occupation (P = .08) 
between participants who completed 6 days and those 
who completed 4 days of monitoring. Likewise, there was 
no difference in age (Mann-Whitney U test; P = .75). The 
mean and standard deviation of each StepWatch output 
are shown in Table 1.
For the 15 participants who completed the 2 3-day 
monitoring periods, the ICCs ranged from 0.438 to 0.912 
(Table 1). The majority of the ICCs (27/33) was above 0.6, 
and thus indicates good or excellent test-retest reliability.
The coefficient of variation ranged from 3.0% to 
36.9% for the 3-day period, 4.1% to 33.8% for the 2-day 
period, and 6.5% to 51.3% for the 1-day period, indicating 
more variation with a shorter monitoring period (Table 1).
Bland Altman analysis showed that the 5 most reli-
able outputs had 95% limits of agreement between 3-day 
periods that were less than 40% (Table 1). These were 
mean steps/day (±39.1%), highest step rate in 1 minute 
(±17.3%) (Figure 1A), highest step rate in 5 minutes 
(±37.4%), peak activity index (±29.8%), and percentage 
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of time with no steps (±9.52%). The 6 other StepWatch 
outputs had 95% limits of agreement between 3-day 
periods greater than 40% (42.0% to 122%). Figure 1B 
shows the Bland Altman plot for 3-day test-retest reli-
ability for highest step rate in 20 minutes as an example 
of wide limits of agreement. There were 3 StepWatch 
outputs that had 95% limits of agreement less than 40% 
for both the 2-day monitoring period (percentage of time 
with no steps, ±13.9%; highest step rate in 1 minute, 
±17.0%; peak activity index, ±31.4%) and the 1-day 
monitoring period (percentage of time with no steps, 
±26.0%; highest step rate in 1 minute, ±25.8%; peak 
activity index, ±39.7%).
There were 15 participants who were not included 
in the 3-day reliability analysis, but had sufficient data to 
test for reliability over 2 days. Thus, Table 2 shows the 
reliability for a 1-day and 2-day monitoring period for 
all 30 participants. The ICCs ranged from 0.317 to 0.861 
(Table 2) and the majority (16/22) was above 0.6, and 
thus indicates good or excellent test-retest reliability. The 
coefficient of variation ranged from 3.4% to 58.8% for 
the 2-day period and 5.4% to 73.6% for the 1-day period, 
again indicating more variation with a shorter monitoring 
period (Table 2). There were 2 StepWatch outputs that 
had 95% limits of agreement less than 40% for both the 
2-day monitoring period (percentage of time with no 
steps, ±12.0%; highest step rate in 1 minute, ±31.9%) and 
the 1-day monitoring period (percentage of time with no 
steps, ±22.1%; highest step rate in 1 minute, ±39.9%).
Discussion
This study has shown that 3-day monitoring of total 
step count by the StepWatch shows excellent test-retest 
reliability, with an ICC of 0.895 and 95% limits of agree-
ment of less than 40%. Four other StepWatch outputs 
Table 1 Mean, Standard Deviation, and Reliability Statistics for StepWatch Outputs for 1-Day, 2-Day, 
and 3-Day Periods 1 Week Apart (n = 15)
StepWatch output
Mean 
(SD)
ICC Coefficient of variation (%) ±95% limits of agreement*
Day 1
Days 1 
& 2
All 3 
days Day 1
Days 1 
& 2
All 3 
days Day 1
Days 1 
& 2
All 3 
days
Mean steps/day 8609 
(2625)
0.512 0.838 0.895 28.8 16.4 11.8 9131 
(101)
4611 
(61.1)
3341 
(39.1)
Number of steps at 
medium rate (>30 and 
<60 steps/minute)
4051 
(1408)
0.472 0.735 0.854 32.9 20.4 13.0 4914 
(112)
3137 
(82.1)
2111 
(53.5)
Number of steps at high 
rate (>60 steps/minute)
1984 
(1272)
0.790 0.823 0.744 51.3 33.8 36.9 2984 
(184)
2202 
(102)
2521 
(122)
Number of steps at 
medium and high rate 
(>30 steps/minute)
5928 
(2205)
0.590 0.863 0.904 31.8 20.3 12.4 6939 
(110)
3538 
(71.9)
2132 
(42.0)
Percentage time inactive 
(no steps)
77.5 
(6.3)
0.612 0.820 0.912 6.5 4.1 3.0 (26.0) (13.9) (9.52)
Peak activity index 
(steps/min)
82.3 
(12.7)
0.809 0.742 0.779 10.7 9.7 6.6 31.4 
(39.7)
25.5 
(31.4)
23.4 
(25.6)
Highest step rate in 60 
minutes (max 60) 
(steps/min)
35.4 
(10.7)
0.675 0.813 0.603 31.2 21.9 17.8 35.8 
(99.2)
23.9 
(66.5)
26.4 
(67.3)
Highest step rate in 30 
minutes (max 30) 
(steps/min)
46.1 
(11.6)
0.715 0.784 0.489 25.9 20.8 17.8 36.6 
(88.6)
27.0 
(59.0)
32.6 
(61.1)
Highest step rate in 20 
minutes (max 20) 
(steps/min)
52.8 
(12.6)
0.766 0.699 0.438 25.0 20.7 18.0 36.2 
(85.1)
33.3 
(61.7)
37.2 
(62.4)
Highest step rate in 5 
minutes (max 5) 
(steps/min)
85.1 
(15.1)
0.727 0.701 0.677 16.3 13.7 10.7 45.6 
(60.3)
35.2 
(42.1)
33.6 
(37.4)
Highest step rate in 1 
minute (max 1) 
(steps/min)
111.8 
(9.3)
0.484 0.769 0.719 6.9 5.7 4.8 27.1 
(25.8)
18.2 
(17.0)
19.3 
(17.3)
* Expressed as absolute value (percentage). 
Abbreviations: SD, standard deviation; ICC, intraclass correlation coefficient.
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Table 2 Reliability Statistics for StepWatch Outputs for 1-Day and 2-Day Periods 1 Week Apart (n = 30)
StepWatch output
ICC
Coefficient 
of variation (%)
±95% limits 
of agreement*
Day 1 Days 1 & 2 Day 1 Days 1 & 2 Day 1 Days 1 & 2
Mean steps/day 0.452 0.852 33.9 17.4 10310 (118) 4666 (64.3)
Number of steps at medium rate (>30 and <60 steps/
minute) 0.595 0.797 34.9 23.9 4424 (124) 2965 (88.1)
Number of steps at high rate (>60 steps/minute) 0.317 0.700 73.6 58.8 6131 (235) 3106 (211)
Number of steps at medium and high rate 
(>30 steps/minute) 0.429 0.841 39.6 26.0 9036 (134) 4196 (93.8)
Percentage time inactive (no steps) 0.703 0.861 5.4 3.4 (22.1) (12.0)
Peak activity index (steps/min) 0.790 0.825 15.7 12.4 45.2 (56.9) 32.2 (43.5)
Highest step rate in 60 minutes (max 60) (steps/min) 0.531 0.752 33.9 21.3 47.4 (113) 27.5 (74.3)
Highest step rate in 30 minutes (max 30) (steps/min) 0.593 0.782 30.6 21.2 56.7 (105) 32.6 (69.8)
Highest step rate in 20 minutes (max 20) (steps/min) 0.634 0.745 30.8 22.3 61.7 (102) 41.9 (73.9)
Highest step rate in 5 minutes (max 5) (steps/min) 0.768 0.758 18.8 16.8 54.6 (68.7) 46.0 (58.7)
Highest step rate in 1 minute (max 1) (steps/min) 0.734 0.841 10.7 8.9 37.9 (39.9) 31.1 (31.9)
* Expressed as absolute value (percentage). 
Abbreviations: SD, standard deviation; ICC, intraclass correlation coefficient.
Figure 1 —Bland-Altman plot with 95% limits of agreement expressed as percentages for a 3-day monitoring period of (A) highest step rate 
in 1 minute and (B) highest step rate in 20 minutes. 
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(percentage of inactive time, highest step rate in 1 minute, 
peak activity index, and highest step rate in 5 minutes) 
also have high ICCs, low coefficients of variation and 
95% limits of agreement less than 40% when measured 
over 3 days. This suggests that these are also reliable 
outputs for a 3-day monitoring period. In contrast, the 
variation of the majority of StepWatch outputs over 1 or 
2 days is higher, indicating lower reliability with shorter 
monitoring periods.
Our reliability results in healthy participants are 
similar to previous work in participants with stroke.5 
Furthermore, these results compare favorably to Busse et 
al’s study of monitoring with the StepWatch over 7 days2 
and suggest that a 3-day monitoring period of total step 
count and peak activity index appears to be at least as 
reliable as a 7-day monitoring period.
An inherent challenge in measuring the reliability 
of daily activity levels is that there is a natural variation 
that occurs from day to day, both for the number of steps 
taken and for the rate of stepping. It can be difficult for 
one reliability study to differentiate between this natural 
variation and measurement error. However, previous work 
has shown consistently that the StepWatch is accurate in 
step counting,3,6,12–16 so the variation detected in this study 
likely reflects true daily variation in activity levels. A 
potential source of error in the StepWatch is interpretation 
of certain activities such as cycling or leg swinging as 
steps.17 However the total steps accrued with such move-
ments is likely to be negligible over a 24 hour period.
Although all participants wore the StepWatch for at 
least 2 periods of 2 days, only half wore it for 2 periods of 
3 days, as instructed. This compliance rate is considerably 
lower than previous work in stroke where 74% (40/54) 
of participants wore the monitor for the full period. 
Reasons for missing days included forgetting to wear the 
monitor, wearing the monitor upside down or deliberately 
not wearing the monitor for fear of damage (eg, during 
skiing or contact sports). The lower compliance rate in 
these participants raises the issue that compliance over 
longer periods or in people who engage in contact sports 
may be problematic.
This study is limited by the number of participants 
who did not wear the monitor for the 3-day monitoring 
period, so the results are based on a smaller number of 
participants, half the number than originally intended. 
However, a separate analysis of reliability for the 30 
participants over 2 and 1-day period corroborates the 
findings of lower reliability for these shorter monitoring 
periods, with only 2 StepWatch outputs (percentage of 
time inactive and highest stepping rate in 1 minute) show-
ing 95% limits of agreement of less than 40%.
The study is limited by its relatively small sample 
size. In addition, the high proportion of students in our 
sample is unlikely to be representative of healthy adults. 
This may limit the generalizability of the findings of this 
study to the general population.
Both the highest step rate in 1 minute and the peak 
activity index had better test-retest reliability than total 
step count over a 3-day monitoring period in this study. 
Highest step rate in 1 minute and peak activity index are 
both based on rate rather than amount of stepping and 
although they may be reflective of maximal physical 
performance in individuals with stroke,18 healthy young 
adults could be expected to achieve cadences of over 
150 steps/min if running. In this study, the mean fastest 
minute of the day was 112 ± 9.3 steps/min, which implies 
that most, if not all, participants did not run during the 
monitoring period. Thus for healthy young adults in this 
study, neither the peak activity index nor the highest step-
ping rate in 1 minute seem to reflect maximal physical 
performance.
The mean steps taken per day by the healthy young 
adults in this study was 8609 ± 2625 steps, which falls 
outside the 95% confidence interval of 9216 to 10,377 
steps calculated by Bohannon in a meta-analysis of 
average daily steps taken by adults under the age of 65.19 
This may also relate to the lower than expected range of 
values for peak activity index and highest stepping rate 
in 1 minute found in this study.
Conclusions
Mean steps/day, highest step rate in 1 and 5 minutes, peak 
activity index, and percentage of inactive time have good 
test-retest reliability over a 3-day monitoring period, with 
lower reliability shown by the other StepWatch outputs 
in healthy young adults. Monitoring over 1 or 2 days is 
less reliable, however compliance over longer periods 
may be problematic for some individuals.
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